{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:53:56Z","timestamp":1792166036337,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M007588\/1"],"award-info":[{"award-number":["MR\/M007588\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M007588\/1"],"award-info":[{"award-number":["MR\/M007588\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M007588\/1"],"award-info":[{"award-number":["MR\/M007588\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"RCUK | MRC | Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/M007588\/1"],"award-info":[{"award-number":["MR\/M007588\/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41591-019-0599-8","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T12:02:52Z","timestamp":1570449772000},"page":"1560-1565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":198,"title":["Safety profile of autologous macrophage therapy for liver cirrhosis"],"prefix":"10.1038","volume":"25","author":[{"given":"Francesca","family":"Moroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Doig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-650X","authenticated-orcid":false,"given":"Alasdair R.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D. M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W. A.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette J.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishwar","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-1471","authenticated-orcid":false,"given":"Jonathan A.","family":"Fallowfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-2561","authenticated-orcid":false,"given":"Stuart J.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico, G., Garcia-Tsao, G. & Pagliaro, L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol. 44, 217\u2013231 (2006).","journal-title":"J. Hepatol."},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1016\/j.jhep.2015.02.040","volume":"62","author":"SJ Forbes","year":"2015","unstructured":"Forbes, S. J., Gupta, S. & Dhawan, A. Cell therapy for liver disease: from liver transplantation to cell factory. J. Hepatol. 62, S157\u2013S169 (2015).","journal-title":"J. Hepatol."},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. J. Clin. Invest. 123, 1887\u20131901 (2013).","journal-title":"J. Clin. Invest."},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield, J. S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56\u201365 (2005).","journal-title":"J. Clin. Invest."},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/hep.24613","volume":"54","author":"AS Gouw","year":"2011","unstructured":"Gouw, A. S., Clouston, A. D. & Theise, N. D. Ductular reactions in human liver: diversity at the interface. Hepatology 54, 1853\u20131863 (2011).","journal-title":"Hepatology"},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nm.2667","volume":"18","author":"L Boulter","year":"2012","unstructured":"Boulter, L. et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med 18, 572\u2013579 (2012).","journal-title":"Nat. Med"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran, P. et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl Acad. Sci. USA 109, E3186\u2013E3195 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","volume":"178","author":"JA Fallowfield","year":"2007","unstructured":"Fallowfield, J. A. et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 178, 5288\u20135295 (2007).","journal-title":"J. Immunol."},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1073\/pnas.1302168110","volume":"110","author":"TG Bird","year":"2013","unstructured":"Bird, T. G. et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc. Natl Acad. Sci. USA 110, 6542\u20136547 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jcyt.2017.05.009","volume":"19","author":"AR Fraser","year":"2017","unstructured":"Fraser, A. R. et al. Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: a novel cellular therapeutic for liver cirrhosis. Cytotherapy 19, 1113\u20131124 (2017).","journal-title":"Cytotherapy"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jcyt.2015.07.016","volume":"17","author":"JK Moore","year":"2015","unstructured":"Moore, J. K. et al. Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study. Cytotherapy 17, 1604\u20131616 (2015).","journal-title":"Cytotherapy"},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/gut.2005.069153","volume":"55","author":"J Foucher","year":"2006","unstructured":"Foucher, J. et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55, 403\u2013408 (2006).","journal-title":"Gut"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.4049\/jimmunol.1100762","volume":"187","author":"JA Hutchinson","year":"2011","unstructured":"Hutchinson, J. A. et al. Cutting Edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J. Immunol. 187, 2072\u20132078 (2011).","journal-title":"J. Immunol."},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jcyt.2017.01.003","volume":"19","author":"J Sharkey","year":"2017","unstructured":"Sharkey, J. et al. Functionalized superparamagnetic iron oxide nanoparticles provide highly efficient iron-labeling in macrophages for magnetic resonance-based detection in vivo. Cytotherapy 19, 555\u2013569 (2017).","journal-title":"Cytotherapy"},{"key":"599_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.24315","volume":"53","author":"JA Thomas","year":"2011","unstructured":"Thomas, J. A. et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function. Hepatology 53, 2003\u20132015 (2011).","journal-title":"Hepatology"},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","volume":"3","author":"PN Newsome","year":"2018","unstructured":"Newsome, P. N. et al. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet Gastroenterol. Hepatol. 3, 25\u201336 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/jlts.2000.18499","volume":"6","author":"ZM Younossi","year":"2000","unstructured":"Younossi, Z. M. et al. Impact of liver transplantation on health-related quality of life. Liver Transpl. 6, 779\u2013783 (2000).","journal-title":"Liver Transpl."},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.45.2.295","volume":"45","author":"ZM Younossi","year":"1999","unstructured":"Younossi, Z. M., Guyatt, G., Kiwi, M., Boparai, N. & King, D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45, 295\u2013300 (1999).","journal-title":"Gut"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/jnci\/djp079","volume":"101","author":"C Le Tourneau","year":"2009","unstructured":"Le Tourneau, C., Lee, J. J. & Siu, L. L. Dose escalation methods in phase I cancer clinical trials. J. Natl Cancer Inst. 101, 708\u2013720 (2009).","journal-title":"J. Natl Cancer Inst."},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","volume":"66","author":"GA Kullak-Ublick","year":"2017","unstructured":"Kullak-Ublick, G. A. et al. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 66, 1154\u20131164 (2017).","journal-title":"Gut"},{"key":"599_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta, R. L. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).","journal-title":"Crit. Care"},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter, J. I. et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48, 124\u2013131 (2007).","journal-title":"Pediatr. Blood Cancer"},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/bjh.12017","volume":"159","author":"H Tinegate","year":"2012","unstructured":"Tinegate, H. et al. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br. J. Haematol. 159, 143\u2013153 (2012).","journal-title":"Br. J. Haematol."},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1373\/jalm.2018.027359","volume":"3","author":"J Day","year":"2019","unstructured":"Day, J., Patel, P., Parkes, J. & Rosenberg, W. Derivation and performance of standardized enhanced liver fibrosis (ELF) test thresholds for the detection and prognosis of liver fibrosis. J. Appl. Lab. Med. 3, 815\u2013826 (2019).","journal-title":"J. Appl. Lab. Med."},{"key":"599_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-10-103","volume":"10","author":"M Friedrich-Rust","year":"2010","unstructured":"Friedrich-Rust, M. et al. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol. 10, 103 (2010).","journal-title":"BMC Gastroenterol."},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/adt.2012.474","volume":"11","author":"MA Karsdal","year":"2013","unstructured":"Karsdal, M. A. et al. Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev. Technol. 11, 70\u201392 (2013).","journal-title":"Assay Drug Dev. Technol."},{"key":"599_CR28","first-page":"303","volume":"5","author":"MJ Nielsen","year":"2013","unstructured":"Nielsen, M. J. et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am. J. Transl. Res. 5, 303\u2013315 (2013).","journal-title":"Am. J. Transl. Res."},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1478-3231.2010.02309.x","volume":"30","author":"SS Veidal","year":"2010","unstructured":"Veidal, S. S. et al. Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int. 30, 1293\u20131304 (2010).","journal-title":"Liver Int."},{"key":"599_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3109\/00365521.2014.996590","volume":"50","author":"DJ Leeming","year":"2015","unstructured":"Leeming, D. J. et al. Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis. Scand. J. Gastroenterol. 50, 584\u2013592 (2015).","journal-title":"Scand. J. Gastroenterol."},{"key":"599_CR31","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1152\/ajpgi.00158.2018","volume":"316","author":"MA Karsdal","year":"2019","unstructured":"Karsdal, M. A. et al. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile. Am. J. Physiol. Gastrointest. Liver Physiol. 316, G25\u2013G31 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"599_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jhep.2005.01.019","volume":"42","author":"TI Huo","year":"2005","unstructured":"Huo, T. I. et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child\u2013Turcotte\u2013Pugh score. J. Hepatol. 42, 826\u2013832 (2005).","journal-title":"J. Hepatol."},{"key":"599_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/TP.0b013e318225db4d","volume":"92","author":"K Barber","year":"2011","unstructured":"Barber, K. et al. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation 92, 469\u2013476 (2011).","journal-title":"Transplantation"},{"key":"599_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-012-0301-5","volume":"15","author":"A Loria","year":"2013","unstructured":"Loria, A., Escheik, C., Gerber, N. L. & Younossi, Z. M. Quality of life in cirrhosis. Curr. Gastroenterol. Rep. 15, 301 (2013).","journal-title":"Curr. Gastroenterol. Rep."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-019-0599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-019-0599-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-019-0599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:00:15Z","timestamp":1684605615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0599-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1038\/s41591-019-0599-8","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"12 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.F. reports personal fees from Novartis, Ferring Pharmaceuticals, Galecto Biotech, Caldan Therapeutics, Gilde Healthcare, Arix Bioscience, Guidepoint and grants from GlaxoSmithKline, Novartis and Intercept Pharmaceuticals, outside the submitted work. S.J.F. has a grant from Syncona to develop macrophages as a therapy. D.J.L., K.M. and M.J.N. are full-time employees at Nordic Bioscience. D.J.L., M.K. and M.J.N. are among the original inventors and patent holders of C3M and PRO-C3. D.J.L. holds stock in Nordic Bioscience. P.C.H. is an advisor for AbbVie, BMS, Eisai Ltd, Falk, Ferring, Gilead, Gore, Janssen, Lundbeck, MSD, Norgine, Novartis, ONO Pharmaceuticals, Pfizer and Roche, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}